View in EDS

KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model.

Saved in:
Bibliographic Details
Title: KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model.
Authors: Tang C; Department of Genitourinary Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ctang1@mdanderson.org., Seo A; Department of Genitourinary Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sherry AD; Department of Genitourinary Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Mayo Clinic, Rochester, MN, USA., Yang P; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hara K; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sircar K; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Genovese G; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jonasch E; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shah AY; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zurita AJ; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kovitz CA; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Campbell M; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Su S; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang J; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ratzel S; Myriad Genetics, Salt Lake City, UT, USA., Acevedo A; Myriad Genetics, Salt Lake City, UT, USA., LaBella M; Myriad Genetics, Salt Lake City, UT, USA., Battey CJ; Myriad Genetics, Salt Lake City, UT, USA., Steiner C; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Urology, University Hospital Leipzig, Leipzig, Germany., Ascione L; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Liu X; Harvard Medical School, Boston, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA., Hannan R; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Shapiro DD; Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA., Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Tannir NM; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Msaouel P; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xu W; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Source: European urology [Eur Urol] 2026 Apr; Vol. 89 (4), pp. 313-317. Date of Electronic Publication: 2026 Feb 28.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41765697
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tang+C%22">Tang C</searchLink>; Department of Genitourinary Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ctang1@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Seo+A%22">Seo A</searchLink>; Department of Genitourinary Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Sherry+AD%22">Sherry AD</searchLink>; Department of Genitourinary Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Yang+P%22">Yang P</searchLink>; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hara+K%22">Hara K</searchLink>; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Sircar+K%22">Sircar K</searchLink>; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Genovese+G%22">Genovese G</searchLink>; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Jonasch+E%22">Jonasch E</searchLink>; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Shah+AY%22">Shah AY</searchLink>; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Zurita+AJ%22">Zurita AJ</searchLink>; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kovitz+CA%22">Kovitz CA</searchLink>; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Campbell+M%22">Campbell M</searchLink>; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Su+S%22">Su S</searchLink>; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Yang+J%22">Yang J</searchLink>; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ratzel+S%22">Ratzel S</searchLink>; Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Acevedo+A%22">Acevedo A</searchLink>; Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22LaBella+M%22">LaBella M</searchLink>; Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Battey+CJ%22">Battey CJ</searchLink>; Myriad Genetics, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Steiner+C%22">Steiner C</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Urology, University Hospital Leipzig, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Ascione+L%22">Ascione L</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; Harvard Medical School, Boston, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hannan+R%22">Hannan R</searchLink>; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Shapiro+DD%22">Shapiro DD</searchLink>; Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Choueiri+TK%22">Choueiri TK</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tannir+NM%22">Tannir NM</searchLink>; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Msaouel+P%22">Msaouel P</searchLink>; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Xu+W%22">Xu W</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227512719%22">European urology</searchLink> [Eur Urol] 2026 Apr; Vol. 89 (4), pp. 313-317. <i>Date of Electronic Publication: </i>2026 Feb 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>7512719 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-7560 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203022838%22">03022838 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41765697
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.eururo.2026.01.004
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 313
    Titles:
      – TitleFull: KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tang C
      – PersonEntity:
          Name:
            NameFull: Seo A
      – PersonEntity:
          Name:
            NameFull: Sherry AD
      – PersonEntity:
          Name:
            NameFull: Yang P
      – PersonEntity:
          Name:
            NameFull: Hara K
      – PersonEntity:
          Name:
            NameFull: Sircar K
      – PersonEntity:
          Name:
            NameFull: Genovese G
      – PersonEntity:
          Name:
            NameFull: Jonasch E
      – PersonEntity:
          Name:
            NameFull: Shah AY
      – PersonEntity:
          Name:
            NameFull: Zurita AJ
      – PersonEntity:
          Name:
            NameFull: Kovitz CA
      – PersonEntity:
          Name:
            NameFull: Campbell M
      – PersonEntity:
          Name:
            NameFull: Su S
      – PersonEntity:
          Name:
            NameFull: Yang J
      – PersonEntity:
          Name:
            NameFull: Ratzel S
      – PersonEntity:
          Name:
            NameFull: Acevedo A
      – PersonEntity:
          Name:
            NameFull: LaBella M
      – PersonEntity:
          Name:
            NameFull: Battey CJ
      – PersonEntity:
          Name:
            NameFull: Steiner C
      – PersonEntity:
          Name:
            NameFull: Ascione L
      – PersonEntity:
          Name:
            NameFull: Liu X
      – PersonEntity:
          Name:
            NameFull: Hannan R
      – PersonEntity:
          Name:
            NameFull: Shapiro DD
      – PersonEntity:
          Name:
            NameFull: Choueiri TK
      – PersonEntity:
          Name:
            NameFull: Tannir NM
      – PersonEntity:
          Name:
            NameFull: Msaouel P
      – PersonEntity:
          Name:
            NameFull: Xu W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-7560
          Numbering:
            – Type: volume
              Value: 89
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: European urology
              Type: main
ResultId 1